Clinical Trial Update: Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating the safety and effectiveness of NXN-188 for the acute treatment of migraine attacks with aura. Status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with Aura

Drugs mentioned

• NXN 188

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine With Aura | Phase 2 | Status: UNKNOWN